| Trade Names: | |
| Status: | Approved (2017) |
| Entry Type: | Protein |
| Molecule Category: | UNKNOWN |
| ATC: | H05BX04 |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Neoplasm Metastasis | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary | Phase 1 | ClinicalTrials |
| Chronic Kidney Disease-Mineral and Bone Disorder; Hyperparathyroidism; Hyperparathyroidism, Secondary; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Neoplasm Metastasis | Phase 1 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Neoplasm Metastasis | Phase 3 | ClinicalTrials |
| Bone Diseases; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Renal Insufficiency, Chronic; Vascular Calcification | Phase 2 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 1 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Neoplasm Metastasis | Phase 2 | ClinicalTrials |
| Kidney Failure, Chronic | Phase 2 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
| Bone Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 2 | ClinicalTrials |
| Hyperparathyroidism; Hyperparathyroidism, Secondary; Kidney Diseases; Neoplasm Metastasis; Renal Insufficiency, Chronic | Phase 3 | ClinicalTrials |
Adverse Reactions
System Organ Classification (SOC)
CONTENTS